Hydrodynamic cavitation mediated phycocyanin extraction from Spirulina paving way for other high value compound extraction coupled with biogas production from post extracted residue to realise a ...

Biotechnology is a broad discipline in which biological processes, organisms, cells or cellular components are exploited to develop new technologies. New tools and products developed by ...

Conduct your own due diligence and consult a financial adviser before making any investment decisions. No sector is left unchanged by the power of AI and digital modeling, and Biotech is no exception.

The deal sees Lilly pay out $9 million upfront plus another $1 million after 15 months to the San Diego biotech, according to Securities and Exchange Commission (SEC) documents filed Feb.

In September, Akeso, a little-known Chinese biotech company founded nearly a decade ago shook up the biotech sector with its new lung cancer drug. Ivonescimab, the new drug, was found in a trial ...

Among that group, Eikon’s round is only surpassed by a $411 million haul for obesity drug developer Verdiva Bio. In addition to Perlmutter, the biotech’s executive suite also includes Merck veterans ...

That, in turn, could eventually hinder the creation of biotech startups in the future, or affect which get launched when. Some biotech investors and entrepreneurs say they are already noticing effects ...

Global biotech leader Amgen opened its $200 million technology and innovation centre in Hyderabad, a facility that will help the U.S. firm ramp up digital capabilities, open more opportunities for ...

The past year has seen two biotech companies working in the field make considerable progress, as the U.S. Food and Drug Administration (FDA) recently gave them the go-ahead to proceed with their ...

CRISPR-based Spotlight Therapeutics has shut down, former CEO Mary Haak-Frendscho, Ph.D., confirmed with Fierce Biotech. The San Francisco-based company housed a cell-specific in vivo gene editing ...

Although a federal judge has temporarily blocked the policy change, government grants to early-stage biotech startups could still face delays or be eliminated entirely, said Chris Gibson ...